一种框架转移生成的癌症新皮托普,可以控制瘤负担在预防和治疗中
Mariam M George1,2, Cory A Brennick1,2, Adam T Hagymasi2
1Department of Immunology, University of Connecticut School of Medicine, Farmington, CT, United States.
Journal of immunology (Baltimore, Md. : 1950)
|April 10, 2025
概括
插入删除 (InDel) 的新表位物显示出癌症免疫治疗的前景. 一个新的InDel产生的新表位在体内通过CD8T细胞控制瘤,证明了治疗潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 由插入或删除 (InDels) 引起的框架移位突变可以创建新的新表位.
- 这些由InDel生成的新表位体缺乏自我对应物,为癌症免疫治疗提供了一个独特的目标.
- 之前的研究表明,InDel新表位可以引起CD8T细胞反应,但体内瘤控制没有被证明.
研究的目的:
- 为了识别和验证能够控制瘤生长的InDel产生的新表位.
- 为了研究一种新型InDel产生的新皮位的特性和有效性.
- 为了比较InDel产生的T细胞枯竭特征与点突变产生的新表位.
主要方法:
- 在小鼠结肠癌线上11个InDels的查.
- 在体内使用预防和治疗模型评估瘤控制.
- 对MHC I等位基因的新位基因亲和力的分析.
- 评估CD8T细胞的反应和耗尽水平.
主要成果:
- 11个已识别的InDels中的一个产生了一种中介瘤控制的新位.
- 这种新位,尽管MHC I的亲和力很低,但通过CD8 T细胞引起了显著的抗瘤活性.
- 这种InDel新表位基因诱导的CD8T细胞与来自点突变衍生新表位基因的CD8T细胞相比,表现出较少的疲劳.
结论:
- 在体内,Del产生的新表位素可以引起强大的抗瘤免疫力.
- 新型InDel新型瘤可以控制瘤,即使具有较低的MHC I亲和力,挑战以前的假设.
- 这些发现突显了InDel产生的新表位细胞在癌症治疗中的治疗潜力,并表明T细胞反应不太耗尽.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
5.9K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Vaccines
278
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
278
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K
